ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04360	Axon guidance	9/58	233/7206	8.84436055273e-05
ko04391	Hippo signaling pathway - fly	5/58	90/7206	0.000739349509019
ko05212	Pancreatic cancer	4/58	83/7206	0.00432980414202
ko05220	Chronic myeloid leukemia	4/58	85/7206	0.00471443762816
ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	2/58	19/7206	0.0099719508346
ko04390	Hippo signaling pathway	5/58	188/7206	0.0171859326141
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	2/58	26/7206	0.0182830306709
ko00310	Lysine degradation	3/58	73/7206	0.0206774642196
ko05169	Epstein-Barr virus infection	5/58	206/7206	0.024462402438
ko04392	Hippo signaling pathway -multiple species	2/58	31/7206	0.0254976306395
ko04919	Thyroid hormone signaling pathway	4/58	143/7206	0.0276033104844
ko04110	Cell cycle	4/58	145/7206	0.0288564053168
ko04917	Prolactin signaling pathway	3/58	87/7206	0.0325763457879
ko05222	Small cell lung cancer	3/58	89/7206	0.0345141218424
ko04722	Neurotrophin signaling pathway	4/58	160/7206	0.0393335549701
ko04910	Insulin signaling pathway	4/58	172/7206	0.0490999677531
ko05161	Hepatitis B	4/58	173/7206	0.0499695315297